HotSheets by Year

 

HotSheets 2009

  • Diagnoses of Cancer Decline in the US
  • Cleveland Clinic Unveils ‘Top 10’ Medical Innovations for 2009
  • Antidiabetic Drugs Linked to Lower Risk of Prostate Cancer
  • Index of Articles Appearing in the 2008 Us TOO HotSheets
  • Doc Moyad’s “What Works and What Is Worthless Column”— The JUPITER trial
  • PSA Doubling Time and Time to Biochemical Failure May Predict Prostate Cancer-Specific Mortality
  • Read more..
  • Us TOO Names 2009 Board Officers & Members
  • FDA Approves Ferring Pharmaceuticals’ Degarelix (generic name) for Advanced Prostate Cancer
  • Geography’s Role in Medicare Cancer Coverage
  • Low-Income Men More Often Diagnosed with Advanced Prostate Cancer
  • FDA Commissioner to Step Down
  • Us TOO Pleasanton, California Chapter Honors Memory of Bill Stone
  • The Doctor’s Note—Dr. Gerald Chodak
  • Read more..
  • Medicare Widens Drugs It Accepts for Cancer
  • Experts Urge Prostate Cancer “Man-o-Gram’
  • Prostate Cancer and Neglect of Other Illnesses
  • Thalidomide for the Treatment of Biochemically Recurrent Prostate Cancer
  • Adjuvant Radiotherapy Improves Survival after Radical Prostatectomy
  • Donated Items Sought for June Online Auction
  • Family History of Prostate Cancer Does Not Affect Treatment Outcomes
  • Read more..
  • Stop PSA Screening in Men Over 75 — But Only Those With Low PSA, Says New Study
  • Researchers Identify Biomarker for Fatal Prostate Cancer
  • Costs Force Cancer Survivors to Pass on Health Care
  • Molecule’s Prevalence May Aid in Deciding Whether to Treat Prostate Cancer
  • GTx Announces Phase III Clinical Development of Toremifene 20 mg on Course Following Safety Review
  • Preventing Prostate Cancer: Good Nutrition May Be Key
  • Personalized Calculator for Future Prostate Cancer Risk
  • Read more..
  • What to Make of the Prostate Cancer Screening Studies
  • A Joint Statement from America’s Prostate Cancer Advocacy, Education and Support Organizations
  • Leading US-Based Prostate Cancer Organizations Develop Joint Policy Agenda
  • PSA Has Higher Predictive Ability in Black Men than in White Men
  • Highlights from the 2009 ASCO GU Cancers Symposium
  • Selected Men with Low-Risk Prostate Cancer Have Good Clinical Outcomes without Immediate Treatment
  • The Doctor’s Note — Dr. Gerald Chodak
  • Read more..
  • Urologists Support Baseline PSA Test at Age 40
  • Provenge® Significantly Improves Survival
  • Living and Loving with Prostate Cancer
  • Us TOO Seeks Board Member Applications
  • Statins May Protect Prostate Health
  • Race May Not Be Key in Cancer Disparities
  • Gene Variant Linked to Aggressive Cancers
  • Agent Orange & Rapidly Recurrent Cancer
  • NCI’s Plan to Accelerate Cancer Research
  • Read more..
  • Signposts Brochure Now Available
  • Young Men with Advanced Cancer & Prognosis
  • False Positives in Screening Reduced by New Test
  • Predicting Prostate Cancer Recurrence
  • Combidex® & Lymph Node Metastasis
  • Us TOO Seeks Board Member Applications
  • Prostate Cancer Yet Another Worry for Women
  • Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
  • Read more..
  • New Urinary Continence Brochure Available
  • Prostate Cancer Patients Should Not Take Selenium
  • Test Improves Prediction of Disease Course
  • Predicting the Return of Prostate Cancer
  • Prostate Cancer Screening: A Question of Common Sense — Dr. Louis Denis, Us TOO Belgium
  • Men with Post-RP pT3 Disease & An Undetectable PSA Benefit from Adjuvant Radiation Therapy
  • Prostate Shrinkage May Reveal High-Grade Cancer
  • Read more..
  • Denosumab Prevents Fractures in Men with Non-Metastatic Prostate Cancer Receiving ADT
  • Coronary Artery Disease Risks with ADT
  • FDA Issues Final Rules to Help Patients Gain Access to Investigational Drugs
  • ‘Watchful Waiting’ Is a Viable Option for Prostate Cancer Patients with Low-Risk Tumors
  • PET/CT Scans May Help Detect Recurring Prostate Cancer Earlier
  • Robotic Surgery May Improve Functional Outcome
  • Larry King Live Video Discusses Early Detection of Prostate Cancer Using the PSA Test
  • Doc Moyad’s “What Works and What Is Worthless Column”— Coenzyme Q10
  • Read more..
  • Link Found Between Common Sexual Infection and Risk of Aggressive Prostate Cancer
  • Every Mustache Makes a Difference
  • New Web-Based Us TOO Prostate Cancer Support Community
  • Soy Pills Fail to Prevent Bone Loss
  • Men Diagnosed with Prostate Cancer in Recent Years Have Better Survival Outcomes
  • Getting Closer to the Origins of Prostate Cancer
  • Protein Tied with Aggressive Prostate Cancer
  • 5th Annual Chicago SEA Blue Prostate Cancer Walk
  • Doc Moyad’s “What Works and What Is Worthless Column”— For BPH, Drugs Are Better than Herbs
  • Read more..
  • Doc Moyad’s “No Bogus Science” Column—Why I Donate to Us TOO International
  • AUA Releases Statement Clarifying Prostate Cancer Testing Recommendations
  • Dendreon Completes Submission of Biologics License Application for PROVENGE®
  • Questions on Breast & Prostate Cancer Screening
  • American Cancer Society Stands by its Screening Guidelines; Mammograms for Women Encouraged
  • FDA Says No to Amgen Bone Drug
  • Radical Prostatectomy Finding in Patients Who Fail Active Surveillance for Prostate Cancer
  • Clinicians Map Group at High Risk for Aggressive “Hidden” Prostate Cancer
  • Read more..

CLICK HERE and opt-in to receive free educational emails from Us TOO.